...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >In vivo dosimetry during conformal radiotherapy: requirements for and findings of a routine procedure.
【24h】

In vivo dosimetry during conformal radiotherapy: requirements for and findings of a routine procedure.

机译:适形放疗期间的体内剂量测定:常规程序的要求和发现。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Conformal radiotherapy requires accurate knowledge of the actual dose delivered to a patient. The impact of routine in vivo dosimetry, including its special requirements, clinical findings and resources, has been analysed for three conformal treatment techniques to evaluate its usefulness in daily clinical practice. MATERIALS AND METHODS: Based on pilot studies, routine in vivo dosimetry quality control (QC) protocols were implemented in the clinic. Entrance and exit diode dose measurements have been performed during two treatment sessions for 378 patients having prostate, bladder and parotid gland tumours. Dose calculations were performed with a CT-based three-dimensional treatment planning system. In our QC-protocol we applied action levels of 2.5% for the prostate and bladder tumour group and 4.0% for the parotid gland patients. When the difference between the measured dose at the dose specification point and the prescribed dose exceeded the action level the deviation was investigated and the number of monitor units (MUs) adjusted. Since an accurate dose measurement was necessary, some properties of the on-line high-precision diode measurement system and the long-term change in sensitivity of the diodes were investigated in detail. RESULTS: The sensitivity of all diodes decreased by approximately 7% after receiving an integrated dose of 10 kGy, for 4 and 8 MV beams. For 34 (9%) patients the difference between the measured and calculated dose was larger than the action level. Systematic errors in the use of a new software release of the monitor unit calculation program, limitations of the dose calculation algorithms, errors in the planning procedure and instability in the performance of the accelerator have been detected. CONCLUSIONS: Accurate in vivo dosimetry, using a diode measurement system, is a powerful tool to trace dosimetric errors during conformal radiotherapy in the range of 2.5-10%, provided that the system is carefully calibrated. The implementation of an intensive in vivo dosimetry programme requires additional staff for measurements and evaluation. The patient measurements add only a few minutes to the total treatment time per patient and guarantee an accurate dose delivery, which is a prerequisite for conformal radiotherapy.
机译:目的:保形放射疗法需要准确了解交付给患者的实际剂量。常规体内剂量测定的影响,包括其特殊要求,临床发现和资源,已针对三种保形治疗技术进行了分析,以评估其在日常临床实践中的有效性。材料与方法:基于初步研究,临床上采用了常规的体内剂量学质量控制(QC)方案。在两次治疗中,对378名患有前列腺癌,膀胱癌和腮腺肿瘤的患者进行了入场和出场二极管的剂量测量。用基于CT的三维治疗计划系统进行剂量计算。在我们的QC协议中,我们对前列腺和膀胱肿瘤组的作用水平为2.5%,对腮腺患者的作用水平为4.0%。当在剂量指定点测得的剂量与规定剂量之间的差值超过作用水平时,将调查偏差并调整监控单元(MU)的数量。由于必须进行准确的剂量测量,因此详细研究了在线高精度二极管测量系统的某些特性以及二极管灵敏度的长期变化。结果:对于4和8个MV光束,在接收到10 kGy的积分剂量后,所有二极管的灵敏度下降了约7%。对于34名(9%)患者,测量剂量与计算剂量之间的差异大于作用水平。检测到在使用新版监控单元计算程序软件时出现系统性错误,剂量计算算法的局限性,计划程序中的错误以及加速器性能的不稳定。结论:使用二极管测量系统,准确的体内剂量测定是追踪在2.5-10%范围内的适形放射治疗期间剂量测定误差的强大工具,只要对该系统进行了仔细的校准即可。强化体内剂量学计划的实施需要额外的人员进行测量和评估。病人的测量结果仅使每位病人的总治疗时间增加了几分钟,并保证了准确的剂量输送,这是适形放疗的前提。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号